A. Kessinger

发表

Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies.

T. Greiner, P. Iversen, G. Zon, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Basal cell and squamous cell skin cancers.

A. Oseroff, N. Lee, J. Grichnik, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial.

P. Iversen, G. Zon, R. Ruddon, 1993, Antisense research and development.

Non-small cell lung cancer.

D. Ettinger, M. Kris, G. Bepler, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN clinical practice guidelines in oncology: kidney cancer.

L. Schwartz, R. Figlin, S. Hancock, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas.

D. Weisenburger, J. Armitage, P. Bierman, 1990, Blood.

Blood stem cell transplantation: factors influencing cellular immunological reconstitution.

J. Lynch, J. Sharp, S. Joshi, 2000, Journal of hematotherapy & stem cell research.

Basal cell and squamous cell skin cancers. Clinical practice guidelines in oncology.

T. Olencki, N. Lee, R. Cheney, 2004, Journal of the National Comprehensive Cancer Network : JNCCN.

Peripheral blood-derived stem cells can be successfully cryopreserved without using controlled-rate freezing.

J. Jackson, A. Kessinger, T. Kloster, 1992, Progress in clinical and biological research.

Effective cryopreservation of cytokine-mobilized autologous peripheral blood stem cells using non-controlled rate freezing.

J. Jackson, A. Kessinger, P. Warkentin, 1994, Progress in clinical and biological research.

Dichroic Thin Layer Films Prepared from Alkanethiol-Coated Gold Nanoparticles

C. Foss, A. Kessinger, Grace Lu, 1997 .

Prognostic factors of chronic graft‐versus‐host disease after allogeneic blood stem‐cell transplantation

J. Armitage, Lynette M. Smith, P. Bierman, 2005, American journal of hematology.

Current concepts in the diagnosis and management of small-cell lung cancer.

A. Kessinger, A. Ganti, R. Lackner, 2010, Oncology.

Association of positive family history with survival of patients with lung cancer.

A. Kessinger, A. Ganti, F. Loberiza, 2009, Lung cancer.

Non-small cell lung cancer: Clinical practice guidelines in oncology

Quynh-Thu Le, Renato Martins, Joe Y. Chang, 2006 .

Weekly vinorelbine and paclitaxel in older patients with advanced non-small cell lung cancer: A phase II Fred and Pamela Buffet Cancer Center Clinical Trials Network study.

Marsha A. Ketcham, J. Meza, A. Kessinger, 2017, Journal of Geriatric Oncology.

Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation.

D. Weisenburger, J. Armitage, P. Bierman, 1989, Blood.

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma.

J. Armitage, P. Bierman, J. Vose, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High dose chemotherapy followed by autologous hematopoietic rescue in Hodgkin's disease: long-term follow-up in 128 patients.

J. Armitage, P. Bierman, J. Vose, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation.

J. Jackson, J. Talmadge, M. Arneson, 1996, Bone marrow transplantation.

Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver

A. Kessinger, Jue Wang, Fenwei Wang, 2010, Journal of oncology.

Factors affecting bone marrow toxicity following administration of carboplatin and paclitaxel in patients with non-small cell lung cancer.

A. Kessinger, A. Ganti, F. Loberiza, 2010, Anticancer research.

Blood stem cell transplantation in non-Hodgkin's lymphoma.

M. Bishop, A. Kessinger, 1997, Cancer investigation.

NCCN clinical practice guidelines in oncology: testicular cancer.

L. Schwartz, R. Figlin, S. Hancock, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy.

J. Armitage, P. Bierman, J. Vose, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Utilization of peripheral blood stem cells in autotransplantation.

A. Kessinger, 1993, Hematology/oncology clinics of North America.

Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy.

D. Weisenburger, J. Armitage, A. Kessinger, 1988, Blood.

Long‐term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies

J. Armitage, P. Bierman, J. Vose, 1992, Cancer.

High-dose hydroxyurea in autologous bone marrow transplantation: a promising "new" agent.

P. Bierman, J. Armitage, A. Kessinger, 1992, Seminars in oncology.

NEUROENDOCRINE TUMORS

J. Olson, D. Ettinger, J. Ajani, 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma.

D. Weisenburger, J. Armitage, P. Bierman, 1989, Blood.

Blood Stem Cell Versus Bone Marrow Transplantation: A Critical Appraisal

A. Kessinger, 2000 .

Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies.

J. Armitage, J. Vose, J. Jackson, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections.

J. Jackson, S. Joshi, A. Kessinger, 1995, Blood.

Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cells.

M. Bishop, S. Joshi, A. Kessinger, 1998, International journal of oncology.

Antitumor therapeutic potential of activated human umbilical cord blood cells against leukemia and breast cancer.

S. Joshi, A. Kessinger, C. Kuszynski, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.

D. Weisenburger, J. Armitage, S. Mann, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome.

P. Iversen, J. Jackson, J. Sharp, 1997, Journal of hematotherapy.

Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemia.

P. Iversen, J. Jackson, M. Bishop, 1994, Progress in clinical and biological research.

The whys and hows of hematopoietic progenitor and stem cell mobilization

A. Kessinger, J. Sharp, 2003, Bone Marrow Transplantation.

Comparison of ISHAGE protocol CD34 cell enumeration with a lineage negative backgating technique.

J. Jackson, M. Bishop, A. Kessinger, 1999, Cytotherapy.

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies

M. Bishop, J. Armitage, A. Kessinger, 1998, Bone Marrow Transplantation.

Collection of autologous peripheral blood stem cells in steady state.

A. Kessinger, 1999, Bailliere's best practice & research. Clinical haematology.

Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients.

J. Jackson, S. Joshi, A. Kessinger, 2000, Cytotherapy.

Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow

J. Vose, J. Talmadge, A. Kessinger, 1997, Bone Marrow Transplantation.

Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor.

P. Bierman, J. Jackson, M. Bishop, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.

R. Bociek, J. Vose, J. Lynch, 2003, Cytotherapy.

Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies.

J. Armitage, P. Bierman, J. Vose, 1995, Experimental hematology.

Mobilization of hematopoietic progenitor cells with Epoetin alfa.

A. Kessinger, G. Sharp, 1996, Seminars in hematology.

High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft.

J. Armitage, J. Vose, J. Jackson, 1994, Blood.

Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics.

J. Lynch, M. Bishop, S. Joshi, 2001, Blood.

Circulating hematopoietic stem cell transplantation

A. Kessinger, J. Sharp, 1996 .

Do autologous peripheral blood cell transplants provide more than hematopoietic recovery?

A. Kessinger, 1995, Stem cells.

The nebraska experience

A. Kessinger, 1995, Stem cells.

Detection of Minimal Residual Disease in Hematopoietic Tissues a

T. Greiner, J. Vose, W. Sanger, 1995 .

High-dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft

J. Armitage, P. Bierman, J. Vose, 1994 .

High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging.

J. Armitage, P. Bierman, J. Vose, 1991, Experimental hematology.

High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease.

J. Armitage, P. Bierman, J. Vose, 1991, Blood.

A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation.

J. Armitage, P. Bierman, J. Vose, 2000, Blood.

The glucagonoma syndrome and its management

A. Kessinger, J. Foley, H. Lemon, 1977, Journal of surgical oncology.

Promises and Pitfalls of Stem Cell Therapy for Promotion of Bone Healing

J. Jackson, A. Kessinger, J. Sharp, 2005, Clinical orthopaedics and related research.

Distribution of plasma glucagon immunoreactivity in a patient with suspected glucagonoma.

A. Kessinger, R. Unger, I. Valverde, 1976, The Journal of clinical endocrinology and metabolism.

Plasma from poorly mobilizing human subjects inhibits cytokine-induced murine blood stem-cell mobilization.

S. Mann, A. Kessinger, J. Sharp, 2002, Cytotherapy.

Is blood or bone marrow betterxs?

A. Kessinger, 1993, Stem cells.

Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.

W. Chan, W. Sanger, P. Iversen, 1995, Leukemia & lymphoma.

Therapy of malignant APUD cell tumors: Effectiveness of DTIC

A. Kessinger, J. Foley, H. Lemon, 1983, Cancer.

Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia

M. Bishop, J. Armitage, A. Kessinger, 2000, Bone Marrow Transplantation.

High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma.

C. D. Wu, D. Weisenburger, P. Bierman, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma.

D. Weisenburger, J. Armitage, P. Bierman, 1989, Blood.

High-dose chemotherapy with autologous marrow transplantation for malignant melanoma. Case reports and literature review.

A. Kessinger, 1985, Journal of the American Academy of Dermatology.

Basal cell and squamous cell skin cancers.

T. Olencki, N. Lee, R. Cheney, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients.

J. Armitage, M. Arneson, A. Kessinger, 1991, American Journal of Medicine.

Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients.

J. Armitage, S. Rennard, M. Arneson, 1991, The American journal of medicine.

A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation.

J. Armitage, P. Bierman, J. Vose, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease.

W. Chan, D. Weisenburger, J. Armitage, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vincristine-laden platelet transfusion for patients with refractory thrombocytopenia.

Lynette M. Smith, A. Kessinger, A. Ganti, 2006, In vivo.

High dose therapy and autologous marrow transplantation as salvage treatment for patients with diffuse large cell lymphoma.

J. Armitage, P. Bierman, S. Jagannath, 1986, European journal of cancer & clinical oncology.

Clinical Features of Sarcomatoid Carcinoma (Carcinosarcoma) of the Urinary Bladder: Analysis of 221 Cases

Chad A. LaGrange, A. Kessinger, Fen Wang, 2010, Sarcoma.

Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilization.

J. Armitage, M. Tempero, M. Bishop, 1995, Journal of hematotherapy.

Peripheral blood stem cell transplantation: historical perspective, current status, and prospects for the future.

A. Kessinger, D. Inwards, David Inwards, 1992, Transfusion medicine reviews.

Peripheral stem cell transplantation for patients with non‐hodgkin lymphoma

J. Armitage, A. Kessinger, 1992 .

Mobilization of blood stem cells

J. Sharp, A. Kessinger, J. Sharp, 1998, Stem cells.

Phase II trial of razoxane in the management of recurrent adenocarcinoma of the ovary: a Gynecologic Oncology Group study.

A. Kessinger, H. Homesley, J. Blessing, 1984, Cancer treatment reports.

Nosocomial Invasive Aspergillosis in Lymphoma Patients Treated with Bone Marrow or Peripheral Stem Cell Transplants

J. Armitage, P. Bierman, J. Vose, 1993, Infection Control & Hospital Epidemiology.

Glucagonoma syndrome is an underdiagnosed clinical entity.

A. Kessinger, J. Edney, Jon S Thompson, 1990, American journal of surgery.

Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.

J. Armitage, J. Vose, M. Bast, 1999, Leukemia & lymphoma.

Counterflow centrifugation apheresis for the collection of autologous peripheral blood stem cells from patients with malignancies: A comparison with a standard centrifugation apheresis procedure

D. Weisenburger, J. Armitage, R. Wigton, 1990, Journal of clinical apheresis.

Peripheral stem cell transplantation in non-Hodgkin's lymphoma patients.

J. Armitage, P. Bierman, J. Vose, 1993, Journal of Hematotherapy.

Consensus conference on high-dose therapy with hematopoietic stem cell transplantation in diffuse large-cell lymphoma. Type of cells, optimal mobilization of stem cells--positive and negative selection.

A. Kessinger, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells.

J. Armitage, P. Bierman, J. Vose, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multiple Organ Dysfunction Syndrome in Bone Marrow Transplantation

J. Armitage, P. Bierman, J. Vose, 1995 .

Urokinase infusion restores function of thrombotically-occluded inferior vena cava apheresis catheters refractory to bolus urokinase therapy

A. Kessinger, W. Haire, R. Lieberman, 1991 .

Autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.

J. Armitage, A. Kessinger, S. Forman, 1990, Hematology/oncology clinics of North America.

Translumbar inferior vena cava catheters: experience with 58 catheters in peripheral stem cell collection and transplantation.

J. Armitage, A. Kessinger, G. Lund, 1990, Transfusion Science.

Dermatofibrosarcoma ProtuberansPractice Guidelines in Oncology

T. Olencki, R. Cheney, J. Michalski, 2012 .

Dermatofibrosarcoma protuberans.

A. Oseroff, N. Lee, J. Grichnik, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

High-dose chemotherapy and autologous transplant with peripheral-blood stem cells.

J. Armitage, J. Vose, A. Kessinger, 1993, Oncology.

VP-16-213 therapy in patients with small-cell carcinoma of the lung after failure on combination chemotherapy.

M. Tempero, A. Kessinger, H. Lemon, 1981, Cancer clinical trials.

Small cell undifferentiated bronchogenic carcinoma: Current status with emphasis upon the role of chemotherapy

A. Kessinger, J. Foley, H. Lemon, 1978, Journal of surgical oncology.

Bartonella-like erythrocyte inclusions in thrombotic thrombocytopenic purpura

W. C. Chan, S. Hinrichs, A. Kessinger, 1997, The Lancet.

Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients

M. Bishop, A. Kessinger, E. Lyden, 2000, Bone Marrow Transplantation.

An ex vivo model of hematopoietic stem cell mobilization.

J. Jackson, A. Kessinger, J. Sharp, 2005, Cytotherapy.

Detection and clinical significance of minimal tumor cell contamination of peripheral stem call harvests

D. Weisenburger, S. Mann, A. Kessinger, 1992 .

VM-26 as a second drug in the treatment of brain gliomas.

A. Kessinger, J. Foley, H. Lemon, 1979, Cancer treatment reports.

Elevated transforming growth factor beta levels in the plasma of cytokine-treated cancer patients and normal allogeneic stem cell donors.

A. Kessinger, J. Sharp, T. McGuire, 2001, Cytotherapy.

Acute renal failure associated with autologous bone marrow transplantation.

D. Weisenburger, P. Bierman, J. Armitage, 1987, Bone marrow transplantation.

Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cells (PBSC).

A. Kessinger, W. Haire, E. Reed, 1997, Transfusion science.

Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells.

D. Weisenburger, J. Armitage, A. Kessinger, 1986, Experimental hematology.

Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia.

D. Weisenburger, J. Armitage, A. Kessinger, 1989, Bone marrow transplantation.

J. Armitage, A. Kessinger, G. Lund, 1991, Bone marrow transplantation.

Prothrombotic hemostatic abnormalities in patients with refractory malignant lymphoma presenting for autologous stem cell transplantation.

J. Armitage, A. Kessinger, M. Conlan, 1991, Bone marrow transplantation.

Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation

J. Lynch, A. Kessinger, J. Lynch, 1998, Bone Marrow Transplantation.

High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma.

J. Armitage, A. Kessinger, M. Duggan, 1991, Bone marrow transplantation.

Clinicopathologic characteristics of primary pleural epithelioid hemangioendothelioma

A. Kessinger, A. Ganti, Chad A Reade, 2011 .

A pilot evaluation of micrometastases for the prediction of outcome in lung cancer.

A. Kessinger, J. Sharp, A. B. Thompson, 2004, Chest.

Autologous transplantation with peripheral blood stem cells: a review of clinical results.

A. Kessinger, 1990, Journal of clinical apheresis.

Therapeutic management of small cell lung cancer. Fewer toxic reactions with lower chemotherapeutic drug dosages.

A. Kessinger, J. Foley, H. Lemon, 1983, JAMA.

Myelodysplastic syndrome after autologous transplant for lymphoma.

A. Kessinger, J. Anderson, J. Vose, 1994, Blood.

Multiple organ dysfunction syndrome in bone marrow transplantation.

J. Armitage, P. Bierman, J. Vose, 1996, Journal of the American Medical Association (JAMA).

Double-lumen inferior vena cava catheters for peripheral stem cell apheresis and transplantations.

A. Kessinger, K. Schmit-Pokorny, L. Stephens, 1995, Transfusion science.

Dermatofibrosarcoma protuberans.

T. Olencki, R. Cheney, J. Michalski, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Nosocomial Invasive Aspergillosis in Lymphoma Patients Treated with Bone Marrow or Peripheral Stem Cell Transplants

J. Armitage, P. Bierman, J. Vose, 1993, Infection Control & Hospital Epidemiology.

Systemic therapy for disseminated basal cell carcinoma: an uncommon manifestation of a common cancer.

A. Kessinger, A. Ganti, 2011, Cancer treatment reviews.

The treatment of metastatic testicular tumors.

A. Kessinger, J. Foley, H. Lemon, 1972, The Journal of urology.

The impact of signet-ring cell carcinoma histology on bladder cancer outcome

A. Kessinger, Fen Wang, Jue Wang, 2012, World Journal of Urology.

A phase II study of estramustine, docetaxel, and exisulind in patients with hormone- refractory prostate cancer: results of cancer and leukemia group B trial 90004.

E. Small, A. Kessinger, N. Vogelzang, 2008, Clinical genitourinary cancer.

Cryopreservation and Infusion of Peripheral Blood Stem Cells

J. Jackson, A. Kessinger, P. Warkentin, 1993 .

Small cell lung cancer.

Renato Martins, Nithya Ramnath, Bruce E Johnson, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

Non-small cell lung cancer.

Renato Martins, Mohammad Jahanzeb, Eric Rohren, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.

J. Armitage, S. Jagannath, S. Tucker, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Malignant pleural mesothelioma.

D. Ettinger, M. Kris, L. Chirieac, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Brain metastasis in patients with non-small-cell lung cancer and epidermal growth factor receptor mutations.

A. Kessinger, A. Ganti, V. Bhatt, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCCN Non – Small Cell Lung Cancer Clinical Practice Guidelines in Oncology

D. Ettinger, M. Kris, G. Bepler, 2010 .

Thrombotic complications of subclavian apheresis catheters in cancer patients: Prevention with heparin infusion

A. Kessinger, J. Edney, J. Landmark, 1990, Journal of clinical apheresis.

Graft versus host disease following transfusion of normal blood products to patients with malignancies

J. Armitage, L. Klassen, A. Kessinger, 1987, Journal of surgical oncology.

The Natural History and Outcomes of the Patients with Carcinosarcoma Involving Kidney and Renal Pelvis

A. Kessinger, Fen Wang, Jue Wang, 2011, Advances in urology.

NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.

Michael A Choti, Gerard M Doherty, M. Choti, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease.

D. Weisenburger, J. Armitage, P. Bierman, 1991, The American journal of medicine.

Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up.

D. Weisenburger, J. Armitage, P. Bierman, 1992, Blood.

The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies.

J. Armitage, A. Kessinger, 1991, Blood.

Detection of Minimal Residual Disease in Hematopoietic Tissues a

T. Greiner, W. Sanger, J. Sharp, 1995, Annals of the New York Academy of Sciences.

GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cells in adhesion molecule expression

A. Kessinger, J. Talmadge, T. Watanabe, 1997, Bone Marrow Transplantation.

High Dose Chemotherapy with Autologous Bone Marrow Rescue for High Grade Gliomas of the Brain: A Potential for Improvement in Therapeutic Results

A. Kessinger, 1984, Neurosurgery.

Therapeutic options for elderly patients with advanced non-small cell lung cancer.

A. Kessinger, A. Ganti, E. Avery, 2009, Cancer treatment reviews.

Non-small cell lung cancer.

D. Ettinger, M. Kris, G. Bepler, 2008, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines TM Version 2 . 2011 Table of Contents Non-Small Cell Lung Cancer Clinical Trials : Categories of Evidence and Consensus :

D. Ettinger, L. Chirieac, A. Kessinger, 2001 .

Translumbar inferior vena cava catheters for long-term venous access.

J. Armitage, A. Kessinger, G. Lund, 1990, Radiology.

Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non–Small-Cell Lung Cancer

Lynette M. Smith, A. Kessinger, A. Ganti, 2016, Journal of global oncology.

Myelodysplastic syndrome after autologous transplant for lymphoma [7]

J. Vose, James R. Anderson, A. Kessinger, 1994 .

The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.

J. Armitage, P. Bierman, J. Vose, 1991, Bone marrow transplantation.

Comparison of two methods of bone marrow processing for autologous bone marrow transplantation.

J. Jackson, J. Armitage, A. Kessinger, 1992, Progress in clinical and biological research.

Cryopreservation and infusion of autologous peripheral blood stem cells.

J. Armitage, A. Kessinger, D. Smith, 1990, Bone marrow transplantation.

Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantation.

J. Jackson, J. Talmadge, A. Kessinger, 1998, Experimental hematology.

Harvesting marrow for autologous transplantation from patients with malignancies.

J. Armitage, A. Kessinger, 1987, Bone marrow transplantation.

Autologous and allogeneic transplantation with peripheral blood stem cells.

A. Kessinger, 1992, Progress in clinical and biological research.

Occult tumor cells detected in autologous blood stem cell harvests have no impact on 5 year outcomes for breast cancer patients with 4–9 positive nodes treated with adjuvant high-dose therapy and stem cell transplantation

A. Kessinger, J. Sharp, E. Reed, 2003, Bone Marrow Transplantation.

A comparison of different cryomedia and methods of freezing human hematopoietic The International Journal of Cell Cloning obtained from bone marrow and peripheral blood for storage

J. Jackson, A. Kessinger, K. Dicke, 1992 .

Merkel cell carcinoma: Clinical practice guidelines in oncology™

A. Oseroff, N. Lee, J. Grichnik, 2006 .

Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy.

D. Weisenburger, J. Armitage, R. Wigton, 1991, Bone marrow transplantation.

Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique.

D. Weisenburger, J. Sharp, S. Joshi, 1992, Blood.

Small cell lung cancer clinical practice guidelines in oncology.

D. Ettinger, J. Crawford, F. Fossella, 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial.

J. Armitage, P. Bierman, J. Vose, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Malignant Pleural MesotheliomaPractice Guidelines in Oncology

D. Ettinger, M. Kris, L. Chirieac, 2012 .

High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.

J. Armitage, P. Bierman, J. Vose, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The International Prognostic Factors Project score for advanced Hodgkin's disease is useful for predicting outcome of autologous hematopoietic stem cell transplantation.

J. Armitage, P. Bierman, R. Bociek, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Myelodysplastic syndrome after autologous transplant for lymphoma [letter; comment]

J. Vose, James R. Anderson, A. Kessinger, 1994 .

Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: the University of Nebraska experience.

C. Haire, L. Klassen, A. Kessinger, 2001, The Journal of rheumatology. Supplement.

Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute myeloid leukemia.

J. Armitage, R. Bociek, W. Sanger, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma.

D. Weisenburger, J. Armitage, P. Bierman, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose cyclophosphamide, thiotepa and hydroxyurea with autologous hematopoietic stem cell rescue: an effective consolidation chemotherapy regimen for early metastatic breast cancer.

B. Edwards, A. Kessinger, E. Reed, 1994, Bone marrow transplantation.

Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation.

D. Weisenburger, J. Armitage, L. Klassen, 1989, Bone marrow transplantation.

Breast carcinoma in bronchoalveolar lavage. A cytologic and immunocytochemical study.

S. Rennard, A. Kessinger, S. Radio, 1989, Archives of pathology & laboratory medicine.

Costs of care associated with high-dose therapy and autologous transplantation for non-Hodgkin’s lymphoma: results from the University of Nebraska Medical Center 1989 to 1995

M. Bishop, J. Armitage, A. Kessinger, 1999, Bone Marrow Transplantation.

Five‐day continuous infusion of 5‐fluorouracil for advanced colorectal, gastric, and pancreatic adenocarcinoma

A. Kessinger, J. Foley, H. Lemon, 1979, Journal of surgical oncology.

Progenitor and lymphoma cells in blood stem cell harvests: impact on survival following transplantation

W. Chan, J. Vose, J. Sharp, 2001, Bone Marrow Transplantation.

A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study.

Marsha A. Ketcham, Lynette M. Smith, S. Batra, 2019, Cancer treatment and research communications.

Autologous blood stem cell versus bone marrow transplantation.

A. Kessinger, M. Körbling, C. Juttner, 1992, Bone marrow transplantation.

Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.

J. Armitage, M. Cowles, J. Vose, 1995, Experimental Hematology.

Granulocyte macrophage colony stimulating factor: high incidence of apheresis catheter thrombosis during peripheral stem cell collection.

A. Kessinger, K. Schmit-Pokorny, L. Stephens, 1993, Bone marrow transplantation.

Hickman catheter‐induced thoracic vein thrombosis. Frequency and long‐term sequelae in patients receiving high‐dose chemotherapy and marrow transplantation

J. Armitage, A. Kessinger, J. Edney, 1990, Cancer.

Effect of prior therapy and bone marrow metastases on progenitor cell content of blood stem cell harvests in breast cancer patients.

A. Kessinger, J. Sharp, E. Reed, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The use of rhIL‐3 for mobilization of peripheral blood The International Journal of Cell Cloning in previously treated patients with lymphoid malignancies

J. Armitage, P. Bierman, J. Vose, 1992 .

Peripheral stem cell transplantation at a single institution.

A. Kessinger, 1993, Journal of hematotherapy.

Detection of malignant cells in histologically normal bone marrow using culture techniques.

D. Weisenburger, S. Joshi, S. Mann, 1987, Bone marrow transplantation.

Clinical outcome of peripheral blood stem cell support

J. Armitage, P. Bierman, J. Vose, 1994, Medical oncology.

Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation

A. Kessinger, R. Steg, Z. Wszolek, 1999, Bone Marrow Transplantation.

High dose cyclophosphamide, etoposide and carmustine and peripheral stem cell transplantation for patients with relapsed hodgkin disease and bone marrow abnormalities

J. Armitage, P. Bierman, J. Vose, 1992 .

Circulating factors may be responsible for murine strain-specific responses to mobilizing cytokines.

J. Jackson, S. Mann, A. Kessinger, 2001, Experimental hematology.

Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.

A. Kessinger, D. G. Heimann, E. Reed, 1996, Bone marrow transplantation.

Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma.

W. Chan, T. Greiner, D. Weisenburger, 1998, Journal of Clinical Oncology.

Pseudoautologous blood stem cell transplantation for refractory chronic graft-versus-host disease

M. Bishop, A. Kessinger, I. Pusic, 2002, Bone Marrow Transplantation.

Case report Pseudoautologous blood stem cell transplantation for refractory chronic graft-versus-host disease

A. Kessinger, I. Pusic, Bishop, 2002 .

Translumbar inferior vena cava catheters.

A. Kessinger, G. Lund, W. Haire, 1991, Bone marrow transplantation.

Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantation.

J. Armitage, J. Lynch, M. Bishop, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In vivo protective effects of tetrapeptide AcSDKP, with or without granulocyte colony-stimulation factor, on murine progenitor cells after sublethal irradiation.

J. Jackson, J. Talmadge, A. Kessinger, 1996, Experimental hematology.

Thrombotic complications of silicone rubber catheters during autologous marrow and peripheral stem cell transplantation: prospective comparison of Hickman and Groshong catheters.

J. Armitage, A. Kessinger, J. Edney, 1991, Bone marrow transplantation.

A murine model of bone marrow micrometastasis in breast cancer

S. Joshi, A. Kessinger, J. Sharp, 2004, Clinical & Experimental Metastasis.

Predictive Ability of Charlson Comorbidity Index on Outcomes From Lung Cancer

A. Kessinger, A. Ganti, F. Loberiza, 2011, American journal of clinical oncology.

Limited-stage small-cell lung cancer: therapeutic options.

A. Kessinger, A. Ganti, W. Zhen, 2007, Oncology.

Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma.

J. Armitage, P. Bierman, J. Vose, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The use of peripheral stem cell support of high-dose chemotherapy.

J. Armitage, A. Kessinger, 1993, Important advances in oncology.

Early Stage Non-Small-Cell Lung Cancer in Octogenarian and Older Patients: A SEER Database Analysis.

A. Kessinger, A. Ganti, V. Shostrom, 2016, Clinical lung cancer.

Hexamethylmelamine (HEX) and melphalan (L-PAM) as second-line therapy in ovarian carcinoma

M. Tempero, A. Kessinger, H. Lemon, 1982 .

Non-small cell lung cancer.

Renato Martins, Mohammad Jahanzeb, Billy W Loo, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: A randomized study

R. Wigton, A. Kessinger, 1987, Journal of surgical oncology.

Association between race and survival of patients with non--small-cell lung cancer in the United States veterans affairs population.

A. Kessinger, A. Ganti, P. Silberstein, 2014, Clinical lung cancer.

Merkel cell carcinoma. Clinical practice guidelines in oncology.

A. Oseroff, N. Lee, J. Grichnik, 2004, Journal of the National Comprehensive Cancer Network : JNCCN.

Effect of Surgical Intervention on Survival of Patients With Clinical N2 Non–Small Cell Lung Cancer: A Veterans’ Affairs Central Cancer Registry (VACCR) Database Analysis

A. Kessinger, I. Aldoss, A. Ganti, 2016, American journal of clinical oncology.

The NCCN Kidney Cancer Clinical Practice Guidelines in OncologyTM

L. Schwartz, R. Figlin, S. Hancock, 2009 .

Use of DTIC in the malignant carcinoid syndrome.

A. Kessinger, J. Foley, H. Lemon, 1977, Cancer treatment reports.

Factors predicting morbidity following hematopoietic stem cell transplantation

J. Armitage, A. Kessinger, L. Stephens, 1997, Bone Marrow Transplantation.

DIFFUSE ALVEOLAR HEMORRAGE IN AUTOLOGOUS BONE MARROW TRANSPLANT RECIPIENTS. REPLY

J. Armitage, S. Rennard, M. Arneson, 1991 .

Quadrichemotherapy for Advanced Ovarian Carcinoma

A. Kessinger, J. Foley, H. Lemon, 1976, Obstetrics and Gynecology.

Outcomes following surgical treatment compared to radiation for stage I NSCLC: a SEER database analysis.

A. Kessinger, A. Ganti, V. Shostrom, 2013, Lung cancer.

A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation.

J. Armitage, P. Bierman, J. Vose, 1998, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intrathecal interleukin-2 for melanomatous meningitis.

A. Kessinger, N. Shonka, M. Aizenberg, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Kidney Cancer.

L. Schwartz, R. Figlin, S. Hancock, 2009, Cancer journal.

Hypercalcemia of malignancy.

A. Kessinger, J. Foley, H. Lemon, 1972, Geriatrics.

Prolonged deficiency of protein C following hematopoietic stem cell transplantation.

A. Kessinger, L. Stephens, G. Kotulak, 1996, Bone marrow transplantation.

Improved palliation of pancreatic carcinoma

A. Kessinger, J. Foley, H. Lemon, 1973, Cancer.

Outcomes following surgical treatment compared to radiation for stage I NSCLC: a SEER database analysis.

A. Kessinger, A. Ganti, V. Shostrom, 2013, Lung Cancer.

Therapeutic options for elderly patients with advanced non-small cell lung cancer.

A. Kessinger, A. Ganti, E. Avery, 2009, Cancer treatment reviews.

Basal cell and squamous cell skin cancers.

A. Oseroff, N. Lee, J. Grichnik, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors.

M. Choti, J. Berlin, M. Heslin, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN clinical practice guidelines in oncology: testicular cancer.

L. Schwartz, R. Figlin, S. Hancock, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Sequential and adjuvant chemotherapy for malignant astrocytoma of the brain

A. Kessinger, J. Foley, H. Lemon, 1978, Journal of surgical oncology.

Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.

John D. Roberts, C. Bloomfield, N. Christakis, 2005, Journal of the National Cancer Institute.

Brain metastasis in patients with non-small-cell lung cancer and epidermal growth factor receptor mutations.

A. Kessinger, A. Ganti, V. Bhatt, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hypercalcemia with breast cancer.

A. Kessinger, L. Sherwood, J. Cohen, 1971, The New England journal of medicine.

CHAPTER 44 – HEMATOPOIETIC STEM CELLS

A. Kessinger, C. Smith, B. Storms, 2000 .

Mini-dose weekly adriamycin therapy for patients with advanced malignant disease at increased risk for adriamycin toxicity.

A. Kessinger, J. Foley, H. Lemon, 1983, American journal of clinical oncology.